Addition of an oral docetaxel treatment (ModraDoc006/r) to androgen deprivation therapy (ADT) and intensity-modulated radiation therapy (IMRT) in patients with high risk N+M0 prostate cancer

Androgen Deprivation ◽

Intensity Modulated ◽

Docetaxel Treatment

Quantification of the Volume Change and Interfractional Motion and Volume of the Prostate for Prostate Cancer Patients undergoing Concurrent Androgen Deprivation Therapy and Intensity Modulated Radiation Therapy

International Journal of Radiation Oncology*Biology*Physics ◽

10.1016/j.ijrobp.2009.07.1364 ◽

2009 ◽

Vol 75 (3) ◽

pp. S597

Author(s):

S. Choi ◽

J.L. Johnson ◽

R. de Crevoisier ◽

L. Dong ◽

J.C. O'Daniel ◽

...

Keyword(s):

Prostate Cancer ◽

Radiation Therapy ◽

Cancer Patients ◽

Volume Change ◽

Androgen Deprivation ◽

Intensity Modulated

Long-term outcomes of dose-escalated intensity modulated radiation therapy alone without androgen deprivation therapy for patients with intermediate and high-risk prostate cancer

Advances in Radiation Oncology ◽

10.1016/j.adro.2016.10.006 ◽

2016 ◽

Vol 1 (4) ◽

pp. 300-309 ◽

Cited By ~ 5

Author(s):

Rafael Gadia ◽

Elton Trigo Teixeira Leite ◽

Ana Luiza Bierrenbach ◽

Fabio Ynoe de Moraes ◽

Daniel E. Spratt ◽

...

Keyword(s):

Prostate Cancer ◽

Radiation Therapy ◽

High Risk ◽

Long Term Outcomes ◽

Intensity Modulated ◽

Risk Prostate Cancer

Long-term outcomes of intensity-modulated radiation therapy combined with neoadjuvant androgen deprivation therapy under an early salvage policy for patients with T3-T4N0M0 prostate cancer

International Journal of Clinical Oncology ◽

10.1007/s10147-015-0867-7 ◽

2015 ◽

Vol 21 (1) ◽

pp. 148-155 ◽

Cited By ~ 9

Author(s):

Takashi Mizowaki ◽

Yoshiki Norihisa ◽

Kenji Takayama ◽

Itaru Ikeda ◽

Haruo Inokuchi ◽

...

Keyword(s):

Prostate Cancer ◽

Radiation Therapy ◽

Androgen Deprivation ◽

Long Term Outcomes ◽

Intensity Modulated

Evaluation of Urinary Outcomes by International Prostate Symptom Scores (IPSS) in Intensity Modulated Radiation Therapy Combined With Androgen Deprivation Therapy for Prostate Cancer

International Journal of Radiation Oncology*Biology*Physics ◽

10.1016/j.ijrobp.2013.06.958 ◽

2013 ◽

Vol 87 (2) ◽

pp. S364-S365

Author(s):

N. Tomita ◽

H. Tachibana ◽

T. Kodaira ◽

N. Soga ◽

Y. Ogura ◽

...

Keyword(s):

Prostate Cancer ◽

Radiation Therapy ◽

Androgen Deprivation ◽

Intensity Modulated ◽

Symptom Scores

Phase I trial of weekly cabazitaxel with concurrent intensity modulated radiation therapy (IMRT) and androgen deprivation therapy (ADT) for the treatment of high-risk prostate cancer (PCa).

Journal of Clinical Oncology ◽

10.1200/jco.2014.32.15_suppl.e16009 ◽

2014 ◽

Vol 32 (15_suppl) ◽

pp. e16009-e16009

Author(s):

Jianqing Lin ◽

Robert Benjamin Den ◽

Timothy N Showalter ◽

Jean H. Hoffman-Censits ◽

Monica McGuire ◽

...

Keyword(s):

Prostate Cancer ◽

Radiation Therapy ◽

High Risk ◽

Phase I ◽

Phase I Trial ◽

Intensity Modulated ◽

Risk Prostate Cancer

Intensity Modulated Radiation Therapy Reduces Gastrointestinal Morbidity in Patients Treated With Androgen Deprivation Therapy for Prostate Cancer

International Journal of Radiation Oncology*Biology*Physics ◽

10.1016/j.ijrobp.2007.07.019 ◽

2007 ◽

Vol 69 (3) ◽

pp. S10 ◽

Cited By ~ 7

Author(s):

N.K. Sharma ◽

T. Li ◽

E.M. Horwitz ◽

A. Pollack ◽

M.K. Buyyounouski

Keyword(s):

Prostate Cancer ◽

Radiation Therapy ◽

Androgen Deprivation ◽

Intensity Modulated

The Outcome for Patients With Pathologic Node-Positive Prostate Cancer Treated With Intensity Modulated Radiation Therapy and Androgen Deprivation Therapy: A Case-Matched Analysis of pN1 and pN0 Patients

International Journal of Radiation Oncology*Biology*Physics ◽

10.1016/j.ijrobp.2016.06.011 ◽

2016 ◽

Vol 96 (2) ◽

pp. 323-332 ◽

Cited By ~ 11

Author(s):

Annelies Van Hemelryk ◽

Gert De Meerleer ◽

Piet Ost ◽

Filip Poelaert ◽

Werner De Gersem ◽

...

Keyword(s):

Prostate Cancer ◽

Radiation Therapy ◽

Androgen Deprivation ◽

Intensity Modulated ◽

Node Positive

Whole-Pelvic Versus Prostate-Only Radiation Therapy in Unfavorable Intermediate-Risk and High-Risk Prostate Cancer Treated with Androgen Deprivation Therapy and Brachytherapy Boost

International Journal of Radiation Oncology*Biology*Physics ◽

10.1016/j.ijrobp.2018.07.293 ◽

2018 ◽

Vol 102 (3) ◽

pp. e150-e151

Author(s):

D.D. Yang ◽

B.A. Mahal ◽

V. Muralidhar ◽

N.E. Martin ◽

M. King ◽

...

Keyword(s):

Prostate Cancer ◽

Radiation Therapy ◽

High Risk ◽

Androgen Deprivation ◽

Intermediate Risk ◽

Risk Prostate Cancer ◽

Brachytherapy Boost

Cost-effectiveness of prostate boost with high-dose-rate brachytherapy versus intensity-modulated radiation therapy in the treatment of intermediate-high risk prostate cancer

Brachytherapy ◽

10.1016/j.brachy.2018.07.009 ◽

2018 ◽

Vol 17 (6) ◽

pp. 852-857 ◽

Cited By ~ 5

Author(s):

Charles C. Vu ◽

Kevin G. Blas ◽

Thomas B. Lanni ◽

Gary S. Gustafson ◽

Daniel J. Krauss

Keyword(s):

Prostate Cancer ◽

Radiation Therapy ◽

Cost Effectiveness ◽

High Risk ◽

High Dose Rate ◽

High Dose ◽

Intensity Modulated ◽

Risk Prostate Cancer

Ten-Year Results From a Phase II Study on Image Guided, Intensity Modulated Radiation Therapy With Simultaneous Integrated Boost in High-Risk Prostate Cancer

Advances in Radiation Oncology ◽

10.1016/j.adro.2019.11.007 ◽

2020 ◽

Vol 5 (3) ◽

pp. 396-403 ◽

Cited By ~ 1

Author(s):

Christian Ekanger ◽

Svein Inge Helle ◽

Daniel Heinrich ◽

Dag Clement Johannessen ◽

Ása Karlsdóttir ◽

...

Keyword(s):

Prostate Cancer ◽

Radiation Therapy ◽

High Risk ◽

Phase Ii Study ◽

Image Guided ◽

Intensity Modulated ◽

Risk Prostate Cancer ◽

Integrated Boost